Claims
- 1. A compound of the formula: ##STR13## wherein R.sup.1 is amino, ureido, lower alkanoylamino, lower alkoxycarbonylamino, lower alkylsulfonylamino, lower alkoxy(lower)alkanoylamino, mono or di or trihalo(lower)alkanoylamino, hydroxy(lower)alkanoylamino, protected hydroxy(lower)alkanoylamino, lower alkoxycarbonyl(lower)alkoxy(lower)alkanoylamino, lower alkylthio(lower)alkanoylamino, mono or di (lower)alkylamino(lower)alkanoylamino, furyl(lower)alkylthioalkanoylamino, lower alkylureido, (C.sub.3 -C.sub.7)-cycloalkanecarbonylamino, (C.sub.3 -C.sub.7)-cycloalkanecarbonylamino having oxo, lower alkyl(C.sub.3 -C.sub.7)-cycloalkanecarbonylamino, furoylamino, nicotinoylamino, (C.sub.3 -C.sub.7)-cycloalkenylamino having amino and oxo, imido, triazolylamino substituted by amino and lower alkyl, benzoisothiazolylamino substituted by oxo, 2-cyano-3-lower alkylguanidino, 2-lower alkanesulfonyl-3-lower alkylguanidino, 2-lower alkanesulfonylguanidino, (1-lower alkylamino-2-nitrovinyl)amino, hydroxy, halogen, cyano, carbamoyl, lower alkoxycarbonyl, benzimidazolylthio or a group of the formula: ##STR14## in which R.sup.4 is hydrogen or sulfamoyl, and R.sup.5 is amino or lower alkoxy,
- R.sup.2 is hydrogen, lower alkyl, lower alkoxy(lower)alkyl, di(lower)alkylamino(lower)alkyl, (C.sub.3 -C.sub.7)-cycloalkyl, lower alkenyl or mono or di or trihalo(lower)alkyl,
- R.sup.3 is hydrogen or lower alkyl; or
- R.sup.2 and R.sup.3 are linked together to form lower alkylene,
- Y is ##STR15## in which R.sup.6 is hydrogen, A is lower alkylene, and
- W is NH; or
- R.sup.2 -W is piperidino or morpholino,
- or pharmaceutically acceptable salt thereof.
- 2. A compound of claim 1, wherein R.sup.1 is lower alkanoylamino or ureido.
- 3. A compound of claim 2, which is selected from the group consisting of 4-(6-acetylaminomethylpyridin-2-yl)-2-(diaminomethyleneamino)thiazole or its mono- or di-hydrochloride, 2-(2-diaminomethyleneamino)-4-(6-ureidomethylpyridin-2-yl)thiazole or its mono- or dihydrochloride, and 4-(6-acetylaminomethylpyridin-2-yl)-2-[(amino)(n-butylamino)methyleneamino]thiazole.
- 4. A compound of claim 2, which is 4-(6-acetylaminomethylpyridin-2-yl)-2-[(amino)(methylamino)methyleneamino]thiazole.
- 5. A pharamaceutical composition which comprises, as an active ingredient, a compound of claim 1 or a pharmaceutically acceptable salt thereof in admixture with pharmaceutically acceptable carriers.
- 6. A method for the therapeutic treatment of ulcer which comprises administering an effective amount of a compound of claim 1 or a pharmaceutically acceptable salt thereof to human or animals.
Priority Claims (3)
Number |
Date |
Country |
Kind |
8920977.9 |
Sep 1989 |
GBX |
|
8928610.8 |
Dec 1989 |
GBX |
|
9012962.8 |
Jun 1990 |
GBX |
|
Parent Case Info
This application is a continuation of application Ser. No. 07/825,832, filed on Jan. 28, 1992, now abandoned, which is a file wrapper continuation of Ser. No. 07/668,915, filed on Mar. 13, 1991, which is a continuation-in-part of Ser. No. 07/571,151 filed on Aug. 23, 1990, both now abaondoned.
US Referenced Citations (1)
Number |
Name |
Date |
Kind |
4735957 |
Takaya et al. |
Apr 1988 |
|
Foreign Referenced Citations (1)
Number |
Date |
Country |
0225186 |
Jan 1985 |
JPX |
Non-Patent Literature Citations (4)
Entry |
Journal of Pharamacology and Experimental Therapeutics, vol. 24, pp. 129-135, 1990. |
Drugs, vol. 32, pp. 15-47, 1986. |
Yamanouchi Pharmaceuticals, "Chemical Abstract" 103(3), 1985, #22581n. |
Yamanouchi Pharmaceutical, "Chemical Abstract" 103(9), 1985, #71307m. |
Continuations (2)
|
Number |
Date |
Country |
Parent |
825832 |
Jan 1992 |
|
Parent |
668915 |
Mar 1991 |
|
Continuation in Parts (1)
|
Number |
Date |
Country |
Parent |
571151 |
Aug 1990 |
|